Current Drug Targets
Title:Editorial
Volume: 20 Issue: 2
Author(s): Ahmad Hatim Sulaiman and Ramli Musa
Affiliation:
Export Options
About this article
Cite this article as:
Sulaiman Hatim Ahmad and Musa Ramli , Editorial, Current Drug Targets 2019; 20 (2) . https://dx.doi.org/10.2174/138945012002181203145147
DOI https://dx.doi.org/10.2174/138945012002181203145147 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
20
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Structural Requirements to Obtain Highly Potent and Selective 18 kDa Translocator Protein (TSPO) Ligands
Current Topics in Medicinal Chemistry Structural and Functional Neuroimaging in Alzheimers Disease: An Update
Current Topics in Medicinal Chemistry Synthetic LXR Agonist Suppresses Endogenous Cholesterol Biosynthesis and Efficiently Lowers Plasma Cholesterol
Current Pharmaceutical Biotechnology Current Indications for Implantable Cardioverter Defibrillators in Non-Ischemic Cardiomyopathies and Channelopathies
Reviews on Recent Clinical Trials Molecular Markers of Tumor Progression in Melanoma
Current Genomics Current Scenario of 1,4-Diazepines as Potent Biomolecules-A Mini Review
Mini-Reviews in Medicinal Chemistry The Effects of Soy Isoflavones in Postmenopausal Women: Clinical Review
Current Drug Therapy Is Combined Angiotensin-converting Enzyme Inhibition and Angiotensin Receptor Blockade Associated with Increased Risk of Cardiovascular Death in Hemodialysis Patients?
Current Hypertension Reviews Monitoring Antiepileptic Drugs: A Level-Headed Approach
Current Neuropharmacology New Targets for Therapy in Polyglutamine (polyQ) Expansion Diseases
Current Drug Therapy Clinical, Genetic, and Neuroimaging Features of Early Onset Alzheimer Disease: The Challenges of Diagnosis and Treatment
Current Alzheimer Research NAP (Davunetide) Provides Functional and Structural Neuroprotection
Current Pharmaceutical Design α-Secretase in Alzheimers Disease and Beyond: Mechanistic, Regulation and Function in the Shedding of Membrane Proteins
Current Alzheimer Research Collective Roles of Molecular Chaperones in Protein Degradation Pathways Associated with Neurodegenerative Diseases
Current Pharmaceutical Biotechnology Implication of Complement System and its Regulators in Alzheimers Disease
Current Neuropharmacology Temporal Progression of Kainic Acid Induced Changes in Vascular Laminin Expression in Rat Brain with Neuronal and Glial Correlates
Current Neurovascular Research The Genetic Landscapes of Inflammation-Driven Gastrointestinal Tract Cancers
Current Pharmaceutical Design Specialized Diet Therapies: Exploration for Improving Behavior in Autism Spectrum Disorder (ASD)
Current Medicinal Chemistry 5-HT Receptor-Associated Protein Networks: New Targets for Drug Discovery in Psychiatric Disorders?
Current Drug Targets Cerebrovascular Ultrasonography for Selecting Patients for Stroke Intervention
Recent Patents on CNS Drug Discovery (Discontinued)